Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc. (ELVN), sold 98,453 shares at $25.07 ($2.5M) on 2024-07-12, disclosed to the SEC on 2024-07-16.
Scheduled sale ($2.5M) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.07 | 17,475 | $438K | 17.8% |
| 2 | $25.07 | 17,475 | $438K | 17.8% |
| 3 | $25.05 | 30,978 | $776K | 31.5% |
| 4 | $25.05 | 30,978 | $776K | 31.5% |
| 5 | $25.01 | 1,547 | $39K | 1.6% |
| Total | $25.06 avg | 98,453 |
| $2.5M |
| 100% |
| Filing → |
| ELVN | SELL | 2025-11-12 | $221K | — | Filing → |
| ELVN | SELL | 2025-10-09 | $268K | — | Filing → |
| ELVN | SELL | 2025-09-10 | $270K | — | Filing → |